Integrity Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$613K Sell
1,677
-87
-5% -$30.8K 0.56% 33
2022
Q3
$570K Sell
1,764
-119
-6% -$37.7K 0.53% 36
2022
Q2
$610K Sell
1,883
-104
-5% -$31.2K 0.6% 30
2022
Q1
$569K Buy
+1,987
New +$511K 0.56% 35

Other funds holding LLY

Integrity Advisory's LLY Position: Q4 2022 in Review

Integrity Advisory reduced its Eli Lilly (LLY) stake by 4.9% in Q4 2022, selling an estimated $30.8K and leaving 1,677 shares worth $613K. The position accounts for 0.56% of the portfolio, ranked #33.

Integrity Advisory first reported a position in LLY in Q1 2022 and has held it in 4 quarters since. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Integrity Advisory held 1,677 shares of Eli Lilly worth $613K as of Q4 2022.
  • Integrity Advisory sold 87 Eli Lilly shares in Q4 2022, an estimated $30.8K.
  • Eli Lilly made up 0.56% of Integrity Advisory's portfolio in Q4 2022, its #33 holding.
  • Integrity Advisory first reported a position in Eli Lilly in Q1 2022 and has held it in 4 quarters since.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Integrity Advisory's 13F filing for Q4 2022, filed 24 Jan 2023.